🇺🇸 FDA
Patent

US 11534474

Oral compositions for bladder regulation and uses thereof

granted A61KA61K36/076A61K36/21

Quick answer

US patent 11534474 (Oral compositions for bladder regulation and uses thereof) held by AYTU BIOPHARMA, INC. expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AYTU BIOPHARMA, INC.
Grant date
Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K36/076, A61K36/21, A61K36/40, A61K36/54